Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q2 FY23 results · Jul–Sep 2022
Unichem Laboratories reported revenue from operations of ₹328.82 crore (up 13.1% from Q2 FY22) and net loss of ₹70.67 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 328.82 | 290.66 | +13.1% | 309.61 | +6.2% |
| Other income | 9.21 | 2.65 | +247.1% | 7.85 | +17.3% |
| Total income | 338.02 | 293.31 | +15.2% | 317.46 | +6.5% |
| Profit before tax | (47.25) | (15.30) | Loss widened | (20.67) | Loss widened |
| Net profit for the period | (70.67) | (12.82) | Loss widened | (23.37) | Loss widened |
| EPS, basic (₹) | (10.04) | (1.82) | Loss widened | (3.32) | Loss widened |
| Net margin (%) | -21.5 | -4.4 | -7.5 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 265.64 | 216.97 | +22.4% | 244.78 | +8.5% |
| Other income | 10.78 | 5.34 | +101.8% | 11.85 | −9.0% |
| Total income | 276.42 | 222.31 | +24.3% | 256.63 | +7.7% |
| Profit before tax | (54.85) | (26.59) | Loss widened | (23.28) | Loss widened |
| Net profit for the period | (75.46) | (21.43) | Loss widened | (23.28) | Loss widened |
| EPS, basic (₹) | (10.72) | (3.04) | Loss widened | (3.31) | Loss widened |
| Net margin (%) | -28.4 | -9.9 | -9.5 |
Consolidated
- Filed with BSE
- 12 Nov 2022, 12:57 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Nov 2022, 12:57 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE